Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines.

Kadowaki M, Yoshioka H, Kamitani H, Watanabe T, Wade PA, Eling TE.

Int J Cancer. 2012 Jan 15;130(2):267-77. doi: 10.1002/ijc.26082. Epub 2011 May 25.

2.

Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A.

Yoshioka H, Kamitani H, Watanabe T, Eling TE.

J Biol Chem. 2008 Nov 28;283(48):33129-37. doi: 10.1074/jbc.M805248200. Epub 2008 Sep 17.

3.

Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.

Kim TY, Zhong S, Fields CR, Kim JH, Robertson KD.

Cancer Res. 2006 Aug 1;66(15):7490-501.

4.

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.

Oncogene. 2003 Jul 17;22(29):4509-16.

PMID:
12881707
5.

Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells.

Shimizu S, Kadowaki M, Yoshioka H, Kambe A, Watanabe T, Kinyamu HK, Eling TE.

Biochem Biophys Res Commun. 2013 Jan 25;430(4):1277-82. doi: 10.1016/j.bbrc.2012.11.137. Epub 2012 Dec 19.

6.

Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.

Costello JF, Berger MS, Huang HS, Cavenee WK.

Cancer Res. 1996 May 15;56(10):2405-10.

8.
10.

Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.

Foltz G, Ryu GY, Yoon JG, Nelson T, Fahey J, Frakes A, Lee H, Field L, Zander K, Sibenaller Z, Ryken TC, Vibhakar R, Hood L, Madan A.

Cancer Res. 2006 Jul 1;66(13):6665-74.

11.

Identification of novel target genes by an epigenetic reactivation screen of renal cancer.

Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P.

Cancer Res. 2006 May 15;66(10):5021-8.

12.

Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation.

Woo SM, Min KJ, Kim S, Park JW, Kim DE, Chun KS, Kim YH, Lee TJ, Kim SH, Choi YH, Chang JS, Kwon TK.

Chem Biol Interact. 2014 Mar 25;211:36-43. doi: 10.1016/j.cbi.2014.01.004. Epub 2014 Jan 16.

PMID:
24440808
13.

Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.

Zou B, Chim CS, Zeng H, Leung SY, Yang Y, Tu SP, Lin MC, Wang J, He H, Jiang SH, Sun YW, Yu LF, Yuen ST, Kung HF, Wong BC.

Gastroenterology. 2006 Dec;131(6):1835-43. Epub 2006 Oct 1.

PMID:
17087954
14.

Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers.

Youssef EM, Chen XQ, Higuchi E, Kondo Y, Garcia-Manero G, Lotan R, Issa JP.

Cancer Res. 2004 Apr 1;64(7):2411-7.

15.

Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status.

Kim IY, Park SY, Kang Y, Thapa D, Choi HG, Kim JA.

Arch Pharm Res. 2011 Feb;34(2):323-30. doi: 10.1007/s12272-011-0219-8. Epub 2011 Mar 6.

PMID:
21380817
16.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

17.

The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer.

Wang X, Baek SJ, Eling TE.

Biochem Pharmacol. 2013 Mar 1;85(5):597-606. doi: 10.1016/j.bcp.2012.11.025. Epub 2012 Dec 7. Review.

18.

Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme.

Schiefer L, Visweswaran M, Perumal V, Arfuso F, Groth D, Newsholme P, Warrier S, Dharmarajan A.

Cancer Gene Ther. 2014 Jul;21(7):297-303. doi: 10.1038/cgt.2014.30. Epub 2014 Jun 20.

PMID:
24948145
19.

Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.

Huang J, Chen K, Huang J, Gong W, Dunlop NM, Howard OM, Bian X, Gao Y, Wang JM.

Carcinogenesis. 2009 Feb;30(2):348-55. doi: 10.1093/carcin/bgn266. Epub 2008 Nov 26.

20.

Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.

Baek SJ, Kim JS, Moore SM, Lee SH, Martinez J, Eling TE.

Mol Pharmacol. 2005 Feb;67(2):356-64. Epub 2004 Oct 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk